Legend Biotech Corp. ADR (LEGN) Social Stream
LEGEND BIOTECH CORP (LEGN) Price Targets From Analysts
Use the tables below to see what analysts covering LEGEND BIOTECH CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 4 | $56 | $50 | $53 | $63.62 | -16.69% |
| 2021-11-19 | 4 | $61 | $51 | $55.75 | $63.62 | -12.37% |
| 2021-11-26 | 5 | $71 | $51 | $59.5 | $63.62 | -6.48% |
| 2022-01-06 | 5 | $71 | $51 | $60.8 | $63.62 | -4.43% |
| 2022-02-16 | 5 | $71 | $51 | $60.8 | $63.62 | -4.43% |
| 2022-03-01 | 5 | $73 | $51 | $62.4 | $63.62 | -1.92% |
| 2022-03-07 | 5 | $73 | $55 | $63.2 | $63.62 | -0.66% |
| 2022-04-19 | 6 | $73 | $53 | $61.5 | $63.62 | -3.33% |
| 2022-06-06 | 6 | $73 | $53 | $62.8 | $63.62 | -1.29% |
| 2022-06-17 | 6 | $77 | $53 | $65.166 | $63.62 | 2.43% |
| 2022-07-15 | 6 | $77 | $53 | $67.6 | $63.62 | 6.26% |
| 2022-10-04 | 6 | $77 | $53 | $66.5 | $63.62 | 4.53% |
| 2022-10-19 | 6 | $77 | $53 | $66 | $63.62 | 3.74% |
| 2022-11-29 | 9 | $77 | $53 | $66 | $63.62 | 3.74% |
| 2022-12-13 | 10 | $77 | $53 | $66.571 | $63.62 | 4.64% |
| 2023-01-05 | 10 | $78 | $53 | $67.428 | $63.62 | 5.99% |
| 2023-01-24 | 10 | $78 | $53 | $68.142 | $63.62 | 7.11% |
| 2023-01-25 | 9 | $78 | $65 | $69.857 | $63.62 | 9.8% |
| 2023-03-29 | 10 | $78 | $65 | $69.375 | $63.62 | 9.05% |
| 2023-04-03 | 11 | $78 | $65 | $69.375 | $63.62 | 9.05% |
| 2023-04-18 | 11 | $78 | $65 | $69.777 | $63.62 | 9.68% |
| 2023-04-20 | 12 | $85 | $65 | $73.5 | $63.62 | 15.53% |
| 2023-04-25 | 12 | $90 | $65 | $75.2 | $63.62 | 18.2% |
| 2023-05-18 | 13 | $90 | $65 | $75.2 | $63.62 | 18.2% |
| 2023-05-22 | 13 | $90 | $65 | $78.7 | $63.62 | 23.7% |
| 2023-05-25 | 15 | $90 | $64 | $77.363 | $63.62 | 21.6% |
The Trend in the Analyst Price Target
Over the past 33 weeks, LEGN's average price target has gone up $11.77.
Over the past 50 weeks, LEGN's average upside potential has been 33.33%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-06 | 4 | 73 | 53 | 62.800 | 46.00 | 36.52% |
| 2022-07-15 | 6 | 77 | 53 | 66.500 | 53.45 | 24.42% |
| 2023-04-18 | 11 | 78 | 65 | 69.777 | 52.24 | 33.57% |
| 2023-04-20 | 12 | 85 | 65 | 73.900 | 63.75 | 15.92% |
| 2023-04-25 | 12 | 90 | 65 | 75.200 | 68.60 | 9.62% |
LEGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 12 | 1 | 2 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
Over the past 39 weeks, LEGN's average broker recommendation rating worsened by 0.06.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LEGN as an investment opportunity.
- LEGN has a higher upside potential (average analyst target price relative to current price) than 638.58% of all US stocks.
- In terms of how LEGEND BIOTECH CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -508.81% of that group.
- In the context of stocks in the large market cap category, LEGEND BIOTECH CORP's number of analysts covering the stock is greater than 822.72% of them.
- LEGEND BIOTECH CORP's average analyst price target is greater than 2723.19% of Pharmaceutical Products stocks.
Stocks similar to LEGEND BIOTECH CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CVAC, QGEN, and SGEN.
View All Top Stocks by Price Target
What is the outlook for LEGN? Use POWR Ratings for clearer insight into price direction.